Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-05-07
1995-10-31
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514311, 514314, 514307, 514336, 514357, 514 18, 514 19, 514444, 514471, 514399, 514365, 514438, 514397, 549 29, 549 60, 549318, 544152, 548204, 5483154, 546147, 546164, 546268, 546329, 530330, 530331, A61K 31535, A61K 3700, C07D40900
Patent
active
054629390
ABSTRACT:
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is (CR.sub.5 R.sub.6).sub.n, (CR.sub.5 R.sub.6).sub.n -aryl, (CR.sub.5 R.sub.6).sub.n -heteroaryl, X-(CR.sub.5 R.sub.6).sub.n, X-(CR.sub.5 R.sub.6).sub.n -aryl or X-(CR.sub.5 R.sub.6).sub.n -heteroaryl wherein aryl and heteroaryl may be optionally substituted;
REFERENCES:
patent: 4965283 (1990-10-01), Klessing et al.
patent: 5055451 (1991-10-01), Krantz et al.
Dolle Roland E.
Graybill Todd L.
Prouty Catherine P.
Schmidt Stanley J.
Speier Gary J.
Balogh Imre (Jim)
Davis William J.
DuPont Paul E.
Ivy C. Warren
Owens Amelia
LandOfFree
Peptidic ketones as interleukin-1.beta.-converting enzyme inhibi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidic ketones as interleukin-1.beta.-converting enzyme inhibi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidic ketones as interleukin-1.beta.-converting enzyme inhibi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1772417